FDA Inspection 1072549 — Xiamen LP Pharmaceutical Co., Ltd.
The FDA completed an inspection of Xiamen LP Pharmaceutical Co., Ltd. on Nov 16, 2018 in Xia Men. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 16, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Xia Men (China)